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CLINICAL INVESTIGATION
Pregnancy in IgA nephropathy
SHINIcHI ABE
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Pregnancy in IgA nephropathy. The impacts of IgA nephropathy and
pregnancy on each other were evaluated in II S women who conceived
168 times between 1970 and 1988. Rates of spontaneous abortion,
normal delivery, live birth and perinatal death were 9, 66, 87 and 4%,
respectively. Infants born to women with glomerular filtration rates
(GFR) lower than 70 mI/mm prior to conception had a higher perinatal
mortality rate (14% vs. 3%, P < 0.001). This was also true if pre-
pregnancy blood pressures were consistently higher than 140/90 mm Hg
(33% vs. 1%, P < 0.001). These were the figures for the whole 18 year
period, but stratification of the data revealed that most adverse results
occurred in the 1970's, during which the perinatal death rate was 9%,
while it was 0% in the 1980's. Eighty-five women were followed for
three years or more. At final follow-up, the rates of decrease in GFR,
and increases in blood pressure and proteinuria were 19, 11 and 7%,
respectively. In most patients the natural history of IgA nephropathy
was similar to that of women who had not experienced pregnancy, but
there were five instances where gestation seemed to accelerate func-
tional loss, with rapid development of end-stage or near end-stage renal
failure. Most women with IgA nephropathy should anticipate few
problems with pregnancy, if they are normotensive and their precon-
ception GFR exceeds 70 ml/min. The gestation in such instances should
have little influence on the natural history of their nephropathy.
IgA nephropathy is one of the most common chronic glomer-
ulonephritic syndromes and frequently affects women at the
peak of their childbearing years. In this latter respect, the
nephrologist is often consulted concerning the advisability of
conceiving or to assist in the management of pregnancies
already in progress in women who have IgA nephropathy. The
specific questions are: 1) whether the pre-existing IgA nephrop-
athy adversely influences the course of pregnancy including
fetal outcome, and 2) whether pregnancy has a negative effect
on the natural course of IgA nephropathy including long-term
prognosis.
The answers to these questions have been a source of
controversy among nephrologists for some time [1—121, but
investigators have recently been moving toward a consensus.
Divergent opinions might be due to the number of patients
studied being too small, inclusion of women with decreased
renal function and/or hypertension, and the decade in which the
investigation was performed. Differences in obstetrical and
renal care at various localities, disparate ways of collecting and
presenting the data, and differences in the natural history of the
disease among ethnic populations could also account for the
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variances. In the current study, the reciprocal influences of
pregnancy and IgA nephropathy were studied by reviewing a
large number of patient records. To minimize the effects of the
aforementioned variables, the data were collected from several
university hospitals throughout Japan.
Methods
Patients
The clinical data for this study were collected from nine
university hospitals and their affiliates in Japan. A large part of
the data were also provided by Dr. S. Tojo, Director of the
Special Research Group for "progressive renal impairment"
sponsored by the Japanese Ministry of Health and Welfare.
The clinical course of 118 women who underwent 168 preg-
nancies from 1970 through 1988, whose underlying renal disease
had been diagnosed as IgA nephropathy according to WHO
criteria [13], were analyzed. In 110 women (93%), renal biopsy
had been performed prior to pregnancy. The other 8 (7%) were
biopsied after delivery or abortion, because of either a previous
history of chronic glomerulonephritis or urinary abnormalities
observed during gestation which persisted after delivery or
termination of pregnancy. Women who underwent elective
abortions were excluded from this survey, as the definitive
reason for the termination was not clear in retrospect.
After delivery or termination of pregnancy, 85 patients who
remained in follow-up for at least three years were assessed in
terms of the effects of pregnancy on the underlying IgA
nephropathy. To discern whether observed declines in GFR
reflected the natural course of the underlying nephropathy or
were an adverse effect of pregnancy, the course of renal
function in pregnant (N = 32) and nonpregnant women (N =
30), whose age and renal function at the time of biopsy were in
the same range, were compared.
Clinical data such as GFR and blood pressure obtained at the
time of biopsy were correlated with obstetrical and long-term
renal outcomes. In the women who conceived more than six
months after biopsy, clinical parameters obtained no longer
than six months before conception were used.
Prematurity was defined as a gestation of less than 37 weeks,
low birth weight as less than 2,500 g, and perinatal death rate as
the sum of stillbirths and deaths within one week of birth [14].
GFR was measured by 24-hour endogenous creatinine clear-
ance and the obtained values were corrected for preconception
body weight and a surface area of 1.73 m2. A woman whose
blood pressure was consistently higher than 140/90 mm Hg was
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Table 1. Results of pregnancies with IgA nephropathy
0. 0
pregnant
women
No. of
pregnancies
Deliveries % Perinatal
deaths
Spontaneous
abortions
Normal Abnormal
.Live
infants %
1970—1980 63 79 53
(67%)
13
(16%)
66
(84%)
7
(9%)
6
(8%)
1981—1988 69 89 58
(65%)
22
(25%)
80
(90%)
0
(0%)
b 9
(10%)
Total ll8 168 ill
(66%)
35
(21%)
146
(87%)
7
(4%)
15
(9%)
a Fourteen women conceived in both the 1970's and 1980'sb < 0.01
defined as hypertensive. Those whose pressures were con-
trolled with medication were also considered to be hyperten-
sive. When compared with prepregnancy levels, decreased
renal function was defined as a 50% or greater increase in serum
creatinine level and/or a 20 mI/mm or more decrease in GFR,
increased blood pressure as an elevation of at least 30/20 mm
Hg and increased proteinuria as a doubling of protein excretion
based on 24-hour urine collection.
For statistical analysis, the y-test and r-test were used. P <
0.05 was considered significant. The values in tables are ex-
pressed as the mean 1 SD.
Results
The outcomes of all 168 pregnancies in 118 women with IgA
nephropathy are depicted in Table 1. A total of 146 (87%) of
these pregnancies resulted in the birth of a live infant. Compli-
cations, which affected 35 (21%) of these deliveries, included
low-birth weight (N 20), often in the setting of prematurity (N
= 3), polyhydramnios (N = 1), premature placental abruption
(N = 1), severe post-partum hemorrhage (N = 1) and preeclamp-
sia (N = 10).
In comparing the rates of perinatal death and live births
between the 1970's and 1980's, the drop in the former from 9%
to 0% is clearly significant (P < 0.01). Abnormal deliveries
increased from 16% to 25%, producing an increase in total live
births (from 84% to 90%), but neither value was statistically
significant.
The perinatal death rates are compared with the overall
perinatal death rates, reported by the Japanese Ministry of
Health and Welfare for the same time periods, that is, 1975 and
1985 (Table 1) [14]. The 1970 to 1980 perinatal death rate in this
series is significantly higher than that of the general population
(9% vs. 1.6%), in contrast to the 1981 to 1988 rate which was
0%.
Table 2 shows the relationships between the clinical param-
eters of blood pressure, both systolic and diastolic, and GFR
before conception and obstetrical outcome. The group which
experienced complications and/or perinatal losses had signifi-
cantly higher preconception blood pressures than the normal
delivery group.
In terms of blood pressure, 90% of pregnancies in normoten-
Table 2. Relationship between clinical parameters at time of biopsy
and obstetrical outcome
Normal
deliveries
Abnormal
deliveries
Perinatal
deaths
Spontaneous
abortions
Blood pressure
Systolic mm Hg 117± 1!
b
125 17 133 29 118 9
b
Diastolic mm Hg 71 9 77 13 82 18 70 6
L a
b
GFR mI/mimi 90 16 93 20 94 17 97 18
a P < 0.05
b p < 0.01
sive women were successful. However, hypertensive women
had a perinatal death rate of 33% (P < 0.001). There were also
significantly fewer normal deliveries and a lower live birth rate
in the latter group than in the normotensive women (Fig. I).
The degree of renal functional impairment also influenced
obstetrical outcome. All women had a GFR >60 mI/mm. When
GFR was greater than 70 mI/mm before conception the perinatal
death rate was 3%, while if GFR was less than 70 mI/mm, the
rate increased to 14% (P < 0.001; Fig. 1).
The long-term effect of pregnancy on the underlying IgA
nephropathy is summarized in Table 3 and Figure 2, which
illustrate the status at final follow-up of 85 gravidas monitored
for at least three years after pregnancy. The rates of decrease in
GFR and increase in blood pressure and proteinuria were 19%,
11% and 7%, respectively. These rates did not differ signifi-
cantly between pregnancies which occurred in the 1970's versus
the 1980's (Table 3). However, as shown in Figure 2, in patients
who were hypertensive or whose GFR was lower than 70
mI/mm before conception, these rates were obviously higher.
For example, among those who had low GFR before concep-
tion, one half (5 out of 10) experienced a further significant
decline. For two women this deterioration necessitated regular
hemodialysis. As to the effect on blood pressure, a significant
increase was found at follow-up in 30% (3 out of 10). The same
Perinatal death rate for the whole Japanese population (per 1,000 live births) as reported by the Japanese Ministry of Health and Welfare
1975 1980 1985
16.0 11.7 8.0
(1.6%) (1.2%) (0.8%)
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GFR 70 mI/mm
(N = 146)
GFR <70 mI/miri
(N = 22)
B Pre-conception BP vs. obstetrical Outcome
Normotensive _________
(< 140/90mm Hg) 71%(N 153)
Hypertensive 20% J( 140/90 mm Hg)(N=15)
50 100
90% 1—i
___________
1*
60%l
50 100
Percent
Fig. 1. Relationships between preconception GFR,20 40 20 blood pressure and obstetrical outcome. < 0.01;
< 0.001.
Table 3. Long-term effect of pregnancy on underlying IgA
nephropathy
Final
conception
No. of
pregnant
women
Decrease
in GFR
Increase
in BP
Increase in
proteinuria
%
1970—1980 36 7 5
(19%) (14%)
1981—1985 49 9
(18%)
4
(8%)
Total 85 16
(19%)
9
(11%)
6
was true for those patients whose blood pressure was consis-
tently higher than 140/90 mm Hg before conception.
Table 4 compares the course of renal function in pregnant and
non-pregnant women with IgA nephropathy. From this table it
is clear that the renal outcome for the majority of women who
underwent pregnancy was very similar to that of controls. At
the end of follow-up there was no difference in GFR between
the pregnant and non-pregnant groups. However, five of the
women who experienced pregnancy progressed to end stage or
near end-stage renal failure, three requiring regular hemodialy-
sis between 1.5 and 3 years after delivery. Two of the controls
ultimately required hemodialysis, but not until five years after
the initial determination of renal function. The clinical data of
these five patients are shown in Table 5.
Although all of these women were initially normotensive and
had GFR above 70 ml/min, those experiencing significant
deterioration could be distinguished from the rest of the patient
population on the basis of their pre-conception biopsy results.
All five had been histologically diagnosed as having moderate or
advanced diffuse proliferative glomerulonephritis with wide-
spread tubulointerstitial lesions such as tubular atrophy, inter-
stitial cell infiltration and fibrosis along with arterioloscierosis.
In contrast, neither widespread tubulointerstitial lesions nor
significant arteriolosclerosis had been observed in women who
had good obstetrical results, even though about 30% had been
diagnosed as having moderate diffuse proliferative glomerulo-
nephritis.
Discussion
Managing pregnancy in patients with underlying glomerulo-
nephritis is becoming more important for clinicians, as nowa-
(8fl days many patients are willing to take on the challenge of
3 pregnancy. Up-to-date information concerning the effects of
(6%) gestation on long-term outcome is necessary. Several studies on
this topic have been published ti—12] but, as Packham et al [9]
have stressed, only a few have dealt with large series of
patients, with but a single, histologically confirmed, glomerular
disorder. IgA nephropathy is one of the most common forms of
glomerulonephritis affecting women of child-bearing age. Ac-
cess to large numbers of women with this disease, who have
conceived, will provide valuable information which should help
nephrologists counsel women with IgA nephropathy who are
considering pregnancy, or who are already pregnant.
In most recent studies the perinatal death rates have been
between 4% and 10% [6—8, 10], with the exception of the 23%
rate calculated from the data of Packham et al [91. Elective
abortions were not included in these figures. Packham et al's
high rate may be due to differences in patient population as well
as the degree of renal dysfunction. In this study all patients had
GFR greater than 60 mI/mm at initial check-up, that is, women
with moderately or severely decreased renal function were not
included. The previously reported rate of 10% [6], based on
data from 30 of the patients included in the present study, has
been reduced to 4%. Still the rate of 4% is excessive, especially
when compared with that of the Japanese population as a whole
[141. However, as mentioned previously, even the rate of 4% is
exaggerated, for in the past decade the rate has decreased to
zero. This probably reflects advances in prenatal care by the
obstetrician-nephrologist team, as well as in neonatal care
nurseries.
As illustrated in Figure 1, women with normal or slightly
impaired renal function generally experienced a favorable out-
come. In addition, most normotensive women had good results.
However, as has been pointed out by several investigators in
A Pre-conception GFR vs. obstetrical outcome
Normal Live
deliveries births
67% l
59% I
5'o
87%
L' i
50 100
Perinatal Spontaneous
deaths abortions
h jJ10%
14%
20 40 20
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Table 4. Course of GFR in pregnant and non-pregnant wornen with IgA nephropathy
At
biopsy
I 2 3 4 5
years
Pregnant mI/mm
(N = 32)
Non-pregnant mI/mm
(N = 30)
81 13
88 16
91
86
19
19
85 17
80 15
81 16 73
78 18 72
22
21
69 26
69 26
In the above data, all pregnancies occurred within 2 years of the renal check-up with biopsy. Part of the data for non-pregnant women provided
by Kobayashi Y and Moriya R.
Table 5. Clinical parameters of patients whose renal functional loss progressed after delivery
Age at
biopsy
years
GFR
before
pregnancy
GFR
at final
follow-up
BP
before
pregnancy
mm Hg
Proteinuria
before
pregnancy
g/day
Biopsy findings
Degree of
glomerular
proliferation
Tubulo-
interstitial
lesions
Arteriolo-
sclerosismi/mm
25 85 22 124/88 1.5 moderate (++) (—)
24 100 36 118/70 0.5 moderate (+) (—)
26 70 HD 140/90 0.9 moderate (+) (+)
25 70 HD 122/80 1.0 advanced (++) (+)
23
(Average p
78
reconception paramete
HD
rs; 32 patients)
130/86 1.2 advanced (++) (+)
25±3 81±13 69±26 119±10/74+9 0.6±0.4
Abbreviation HD is receiving regular hemodialysis.
Degree of glomerular proliferation: minor, mild, moderate, advanced.
Degree of tubulointerstitial lesions: —, +, ++.
Degree of arteriolosclerosis: —, +, ++.
this field, women with decreased renal function and/or hyper-
tension tend to have more obstetrical complications [1, 2, 6—8,
12]. Thus, it is advisable for patients planning to attempt
pregnancy to have normal blood pressure and a GFR greater
than 70 mllmin before conception, and if in such women the
disease appears stable, they can be advised that with meticu-
lous prenatal care the chance of delivering a healthy infant is
excellent.
Regarding the effect of pregnancy on the underlying IgA
nephropathy, the overall rates of decrease in GFR, and in-
creases in blood pressure and proteinuria at final follow-up were
not significantly higher than those of IgA nephropathy patients
who had never undergone pregnancy. However, in patients
who were hypertensive or who had GFRs below 70 mI/mm
before conception, the long-term prognosis was less optimistic.
In order to evaluate whether the small decrements in GFR
observed at follow-up reflected the natural course of the renal
disease or represented an adverse effect of pregnancy, the
course of renal function in a group of patients was compared
with that of women with IgA nephropathy who had never been
pregnant. These groups were matched for age and GFR at the
start of analysis and their renal function was monitored over the
next five years. As shown in Table 4, there were no significant
differences between the two groups. These results agree with
those of Jungers et at [12] who concluded that pregnancy had no
general influence on the course of IgA nephropathy.
A minority of patients (N = 5)progressed to end stage or near
end-stage renal failure. It was of interest that these women
could be distinguished from the rest of the patient population on
the basis of their pre-conception biopsy results [6]. Although
their GFR were equal to or higher than 70 mI/mm at the initial
check-up, they had severe histological impairment not only in
the glomeruli but also in arterioles, tubules and the interstitium.
Packham et al [15] reported a very high rate of IgA nephropathy
A Decrease in GFR
19%
HD
HDV 50%
40%
Total(N = 85)
Decrease in GFR
before pregnancy(N = 10)
Hypertensive
before pregnancy
(N = 5)
B Increase in BP
:i 11%
30%
20%
60 20 40
Percent
20 40
C Increase in
proteinuria
] 7%
:::i 10%
20%
Fig. 2. Long-term effect of pregnancy on
2 underlying IgA nephropathy: status at final0 40 follow-up. Abbreviation HD is receiving regular
hemodialysis.
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with superimposed focal and segmental proliferative lesions in
their patients who eventually experienced significant deteriora-
tion in renal function. In addition, obstetrical complication and
fetal loss rates were very high among these women. In the
majority of patients, however, pregnancy does not appear to
worsen underlying IgA nephropathy.
In conclusion, patients with IgA nephropathy will probably
tolerate pregnancy well and it will most likely not have an
adverse effect on the course of their underlying disease, if blood
pressure is normal and GFR more than 70 ml/min before
conception. In cases with hypertension, however, the rate of
live birth is extremely low if hypertension exists before preg-
nancy and/or is not controlled during gestation.
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